Contract Pharmaceutical Dose Manufacturing Industry - Composition, Size, Market Share and Outlook, 2021 Edition

Table of Contents
About GlobalData
Executive Summary
Players
Trends
Industry Analysis
Industry Size and Structure
Industry Demographics
Major Developments Affecting Industry Structure
Industry Size and Growth
Dose Manufacturing
CMO Market Shares
Characteristics of the Largest CMOs
CMOs and Payment Protection Program Loans
Analyzing Recent Dose CMO Industry Performance
The COVID-19 Impact
Public CMO Sales Analysis
Changing Nature of Innovative FDA Approvals
What It Means
Value Chain
Companies
Appendix
Methodology
Bibliography
Primary Research - Key Opinion Leaders
Further Reading
About the Authors
Contact Us

List of Tables
Table 1: Dose CMO Trends, 2020
Table 2: Summary of CMO Facility Acquisition of Dose Facilities Activity, 2013-2020
Table 3: CMO Acquisitions of Dose Manufacturing Facilities, 2020
Table 4: Dedicated CMO Acquisitions of Companies with Commercial Dose Capabilities, 2020
Table 5: PE Investments in the Dose CMO Industry, 2013-2020
Table 6: Revenue Composition and Strategic Orientation of Leading CMOs, 2020
Table 7: Geographical Reach of Dose CMO Universe, 2021
Table 8: Further Reading

List of Figures
Figure 1: Leading Dose CMOs, 2020
Figure 2: Top Contract Dose Trends in the CMO Industry, 2020
Figure 3: Geographic Reach of the Dose CMO Universe, 2020
Figure 4: Geographic Distribution of Commercial Dose Facilities, 2020
Figure 5: Geographic Distribution of Commercial Dose Injectable Facilities, 2020
Figure 6: Dose CMO Injectable Facility Percentage Change from 2019 to 2020 (%)
Figure 7: CMO Count by Dose Revenue Tiers, 2020
Figure 8: Dose CMO Market Size by Revenue, 2010-2020
Figure 9: Components of Growth for Dose CMOs, 2019-2020
Figure 10: Dose CMO Dosage Form Revenue Segments in 2020 ($B)
Figure 11: Dose CMO Dosage Form Revenue Segments Percentage Change from 2019-2020 (%)
Figure 12: Dose CMO Industry Market Share by Company Revenue Tier, 2020
Figure 13: Dose CMO Industry Market Share by Company Revenue Tier Percentage Change from 2019-2020 (%)
Figure 14: PPP Loan Borrowing by CMOs, 2020
Figure 15: PPP Loans Received by CMO Contract Business Model, 2020
Figure 16: COVID-19 Vaccine and Therapy Contract Manufacturing Agreements
Figure 17: CMO Services Sector Performance, 2020
Figure 18: Revenue Growth for Public CMOs
Figure 19: NME Approvals Requiring Special Handling, 2011-2020
Figure 20: Outsourcing of Orphan NMEs, 2011-2020
Figure 21: The Contract Manufacturing Value Chain